Avi Eliassaf
Chief Operating Officer at Anima Biotech, Inc.
Avi Eliassaf active positions
| Companies | Position | Start | End |
|---|---|---|---|
Anima Biotech, Inc.
 Anima Biotech, Inc. Pharmaceuticals: MajorHealth Technology Anima Biotech, Inc. develops translation control therapeutics, a new class of drugs that specifically control protein translation as a novel strategy against hard and undruggable targets. The firm?s platform combines new biology with proprietory image analysis and big data software. The company was founded Yochi Slonim and Zeev Smilansky and is headquartered in Bernardsville, NJ. | Chief Operating Officer | - | - |
Career history of Avi Eliassaf
Former positions of Avi Eliassaf
| Companies | Position | Start | End |
|---|---|---|---|
SalesPredict SW Ltd.
 SalesPredict SW Ltd. Electronics DistributorsDistribution Services SalesPredict SW Ltd. developed predictive analytics solutions. The firm offered solution for marketing, sale and customer management. The company was founded by Yaron Zakai-Or and Kira Radinsky in 2012 and was headquartered in Netanya, Israel. | Director of Finance/CFO | - | - |
Training of Avi Eliassaf
| Ben-Gurion University of the Negev | Undergraduate Degree |
Statistics
International
| Israel | 3 |
| United States | 2 |
Operational
| Director of Finance/CFO | 1 |
| Undergraduate Degree | 1 |
| Chief Operating Officer | 1 |
Sectoral
| Distribution Services | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
SalesPredict SW Ltd.
SalesPredict SW Ltd. Electronics DistributorsDistribution Services SalesPredict SW Ltd. developed predictive analytics solutions. The firm offered solution for marketing, sale and customer management. The company was founded by Yaron Zakai-Or and Kira Radinsky in 2012 and was headquartered in Netanya, Israel. | Distribution Services |
Anima Biotech, Inc.
Anima Biotech, Inc. Pharmaceuticals: MajorHealth Technology Anima Biotech, Inc. develops translation control therapeutics, a new class of drugs that specifically control protein translation as a novel strategy against hard and undruggable targets. The firm?s platform combines new biology with proprietory image analysis and big data software. The company was founded Yochi Slonim and Zeev Smilansky and is headquartered in Bernardsville, NJ. | Health Technology |
- Stock Market
- Insiders
- Avi Eliassaf
- Experience
